Literature DB >> 5267139

Hypoxanthine-guanine phosphoribosyltransferase deficiency: activity in normal, mutant, and heterozygote-cultured human skin fibroblasts.

W Y Fujimoto, J E Seegmiller.   

Abstract

Cultured skin fibroblasts from patients deficient for the enzyme hypoxanthine-guanine phosphoribosyltransferase (PRT) activity show very low but nevertheless significant levels of apparent PRT enzyme despite absence of detectable activity (<0.004% of normal) in erythrocytes of the same patients. In fibroblasts this mutant enzyme is more heat labile than the normal enzyme. These findings indicate that PRT deficiency in this disorder is not due to a deletion mutation of the PRT locus.Individual cultured skin fibroblasts from heterozygote females for PRT deficiency show normal, intermediate, or very low levels of PRT activity. The mosaicism demonstrated in the heterozygotes for this X-linked disorder accounts for the cells with normal and very low activities of PRT. Intermediate activity can best be explained by the phenomenon of metabolic cooperation presumably from the transfer of either PRT enzyme or messenger RNA, from normal to mutant cells.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5267139      PMCID: PMC282946          DOI: 10.1073/pnas.65.3.577

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  13 in total

1.  A FAMILIAL DISORDER OF URIC ACID METABOLISM AND CENTRAL NERVOUS SYSTEM FUNCTION.

Authors:  M LESCH; W L NYHAN
Journal:  Am J Med       Date:  1964-04       Impact factor: 4.965

2.  A specific enzyme defect in gout associated with overproduction of uric acid.

Authors:  W N Kelley; F M Rosenbloom; J F Henderson; J E Seegmiller
Journal:  Proc Natl Acad Sci U S A       Date:  1967-06       Impact factor: 11.205

3.  Biochemical diagnosis of an X-linked disease in utero.

Authors:  W Y Fujimoto; J E Seegmiller; B W Uhlendorf; C B Jacobson
Journal:  Lancet       Date:  1968-08-31       Impact factor: 79.321

Review 4.  Hypoxanthine-guanine phosphoribosyltransferase deficiency in gout.

Authors:  W N Kelley; M L Greene; F M Rosenbloom; J F Henderson; J E Seegmiller
Journal:  Ann Intern Med       Date:  1969-01       Impact factor: 25.391

5.  Biochemical bases of accelerated purine biosynthesis de novo in human fibroblasts lacking hypoxanthine-guanine phosphoribosyltransferase.

Authors:  F M Rosenbloom; J F Henderson; I C Caldwell; W N Kelley; J E Seegmiller
Journal:  J Biol Chem       Date:  1968-03-25       Impact factor: 5.157

6.  Inhibition of 5'-nucleotidase from Ehrlich ascites-tumour cells by nucleoside triphosphates.

Authors:  A W Murray; B Friedrichs
Journal:  Biochem J       Date:  1969-01       Impact factor: 3.857

7.  Inherited disorder of purine metabolism. Correlation between central nervous system dysfunction and biochemical defects.

Authors:  F M Rosenbloom; W N Kelley; J Miller; J F Henderson; J E Seegmiller
Journal:  JAMA       Date:  1967-10-16       Impact factor: 56.272

8.  X-linked hypoxanthine-guanine phosphoribosyl transferase deficiency: heterozygote has two clonal populations.

Authors:  B R Migeon; V M Der Kaloustian; W L Nyhan; W J Yough; B Childs
Journal:  Science       Date:  1968-04-26       Impact factor: 47.728

9.  Enzyme defect associated with a sex-linked human neurological disorder and excessive purine synthesis.

Authors:  J E Seegmiller; F M Rosenbloom; W N Kelley
Journal:  Science       Date:  1967-03-31       Impact factor: 47.728

10.  Metabolic co-operation between biochemically marked mammalian cells in tissue culture.

Authors:  H Subak-Sharpe; R R Bürk; J D Pitts
Journal:  J Cell Sci       Date:  1969-03       Impact factor: 5.285

View more
  30 in total

1.  Developmental changes in purine phosphoribosyltransferases in human and rat tissues.

Authors:  A Adams; R A Harkness
Journal:  Biochem J       Date:  1976-12-15       Impact factor: 3.857

2.  Intercellular communication and tissue growth: VIII. A genetic analysis of junctional communication and cancerous growth.

Authors:  R Azarnia; W R Loewenstein
Journal:  J Membr Biol       Date:  1977-06-03       Impact factor: 1.843

3.  Rapid prenatal diagnosis of HG-PRT deficiency using ultra-microchemical methods.

Authors:  P Hösli; C H de Bruyn; F J Oerlemans; M Verjaal; R E Nobrega
Journal:  Hum Genet       Date:  1977-06-30       Impact factor: 4.132

4.  Purine nucleotide synthesis in lymphoblasts cultured from normal subjects and a patient with Lesch-Nyhan syndrome.

Authors:  A W Wood; M A Becker; J E Seegmiller
Journal:  Biochem Genet       Date:  1973-07       Impact factor: 1.890

5.  Simplified methods for the measurement and electrophoretic demonstration of hypoxanthine-guanine phosphoribosyl transferase. Evidence for dimeric enzyme structure in various mammals.

Authors:  H H Ropers
Journal:  Humangenetik       Date:  1972

6.  Electrophoretic properties of hypoxanthine-guanine phosphoribosyl transferase in erythrocytes of subjects with Lesch-Nyhan syndrome.

Authors:  B Bakay; W L Nyhan
Journal:  Biochem Genet       Date:  1972-04       Impact factor: 1.890

7.  Absence of demonstrable linkage of human genes for enzymes of the purine and pyrimidine salvage pathways in human-mouse somatic cell hybrids.

Authors:  C Long; T Chan; V Levytska; T Kusano; H Green
Journal:  Biochem Genet       Date:  1973-07       Impact factor: 1.890

8.  Chemical mutagenesis at the phosphoribosyltransferase locus in cultured human lymphoblasts.

Authors:  K Sato; R S Slesinski; J W Littlefield
Journal:  Proc Natl Acad Sci U S A       Date:  1972-05       Impact factor: 11.205

9.  Purine metabolism in normal and thioguanine-resistant neuroblastoma.

Authors:  A W Wood; M A Becker; J D Minna; J E Seegmiller
Journal:  Proc Natl Acad Sci U S A       Date:  1973-12       Impact factor: 11.205

10.  Expression of purine overproduction in a series of 8-azaguanine-resistant diploid human lymphoblast lines.

Authors:  J E Lever; G Nuki; J E Seegmiller
Journal:  Proc Natl Acad Sci U S A       Date:  1974-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.